CVS vs. MDLN: CVS Health vs. Medline Stock Comparison

Company Profile

CVS Health (CVS) and Medline (MDLN) both fall under the Health Care Equipment & Services industry group, but CVS is classified in Health Care Providers & Services while MDLN is classified in Health Care Equipment & Supplies.

CVS Health (CVS) has been public since February 21, 1973, giving it decades of market history across multiple cycles, while Medline (MDLN) listed only on December 17, 2025 and lacks comparable through-cycle data.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

Medline (MDLN) reports a negative beta of -0.93, suggesting inverse market sensitivity over the measurement window. That is uncommon for ordinary equities and can reflect commodity-linked or hedge-like exposure, but it can also come from statistical noise. CVS Health (CVS) has a non-negative beta of 0.60.

Risk-Adjusted Performance

Risk-Return Positioning

Both CVS and MDLN need 1-year volatility and 1-year return to plot risk-return positioning.

Risk-Adjusted Metrics

Profitability

Both CVS Health (CVS) at 14.36% and Medline (MDLN) at 4.85% land near their industries’ usual ROE ranges, so capital efficiency looks broadly in line with peers on both sides.

Both CVS Health (CVS) at 2.64% and Medline (MDLN) at 1.85% keep about the typical share of revenue as profit for their industries — neither bottom line stands out from peers.

Both CVS Health (CVS) at 2.72% and Medline (MDLN) at 5.22% run core operations about as efficiently as their industries’ norm — neither stands out on operating profitability.

Profitability Metrics

Growth

Only one side can be read here: CVS Health (CVS) reports revenue growth of 7.85%, ranked against its industry; Medline (MDLN) has no revenue growth figure this period.

Medline (MDLN) at 117.38% delivers above-range EPS growth, while CVS Health (CVS) at -62.02% falls into the bottom quartile — a wide split in earnings momentum.

Growth Metrics

Financial Strength

Medline (MDLN) at 4.04 carries current ratio above its industry’s typical mid-range, while CVS Health (CVS) at 0.85 runs in the tighter-liquidity quartile — different working-capital profiles, both worth examining.

Medline (MDLN) at 0.65 carries an industry-typical debt-to-equity mix, while CVS Health (CVS) at 0.93 uses more debt funding than most peers.

Financial Strength Metrics

Dividends

Medline (MDLN) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile CVS Health (CVS) reports a yield of 3.27%, ranking against industry peers normally.

Medline (MDLN) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile CVS Health (CVS) reports a payout of 30.89%, ranking against industry peers normally.

Dividend Metrics

Valuation

CVS Health (CVS) at 9.74 sits in the cheaper P/E ratio quartile, while Medline (MDLN) at 90.09 trades above its peer range — a wide earnings-valuation gap relative to industry peers.

CVS Health (CVS) at 0.26 sits in the cheaper P/S ratio quartile while Medline (MDLN) at 1.70 prices around its industry’s middle — CVS costs less per dollar of sales, though read it alongside growth and margins.

CVS Health (CVS) at 1.33 sits in the lower P/B ratio quartile against book while Medline (MDLN) at 2.95 is valued near its industry’s middle — CVS is cheaper on assets, though weigh it against ROE and asset quality.

Valuation Metrics